Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit, Scinai Bioservices Inc.
JERUSALEM, Dec. 16, 2024 /PRNewswire/ — Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) (“Scinai” or the “Company”), a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and providing CDMO services through its Scinai
Ideal Power Secures First Design Win for Solid-State Circuit Breakers
AUSTIN, Texas, Dec. 16, 2024 /PRNewswire/ — Ideal Power Inc. (Nasdaq: IPWR) (“Ideal Power,” the “Company,” “we,” “us” or “our”), developer and innovative provider of the highly efficient and broadly patented B-TRAN® bidirectional se
Diamond Hill Launches New Securitized Credit Fund
COLUMBUS, Ohio, Dec. 16, 2024 /PRNewswire/ — Diamond Hill, a boutique investment management firm with a long-term, valuation-disciplined approach across multiple asset classes, today announced the launch of the Diamond Hill Securitized Credit Fund. Structured as an interval fund, the Fund wil
iXpressGenes Appoints John Schmitt as CEO, Announces Nationwide TAI Test Launch
HUNTSVILLE, Ala., Dec. 16, 2024 /PRNewswire/ — iXpressGenes (iXG), a biotechnology company transforming trauma care, is proud to appoint co-founder John Schmitt as Chief Executive Officer (CEO) and announce the nationwide launch of its Trauma Autoimmune Indicator (TAI) test, available by Q2 20
The Everglades Foundation Wins Suncoast Regional EMMY Award for Groundbreaking Everglades Stories from Across the Watershed
Series Highlights Connections and Experiences of People Across the Everglades Ecosystem MIAMI, Dec. 16, 2024 /PRNewswire/ — The Everglades Foundation is proud to announce that its captivating series, Everglades Stories from Across the Watershed, won a Suncoast Chapter of The National Academy o
Genprex Receives Safety Review Committee Approval to Advance to Phase 2 Portion of Acclaim-3 Clinical Trial of Reqorsa® Gene Therapy in Combination with Tecentriq® in Extensive Stage Small Cell Lung Cancer
Genprex Completes Phase 1 Dose Escalation Portion of Acclaim-3 Clinical Trial Results from Phase 1 Dose Escalation Demonstrate Favorable Safety Profile of REQORSA and Tecentriq in ES-SCLC Patients AUSTIN, Texas , Dec. 16, 2024 /PRNewswire/ — Genprex, Inc. (“Genprex” or the “
Rosenberg & Parker Welcomes Allison Thornhill as Vice President, Renewable Energy Practice Leader
ATLANTA, Dec. 16, 2024 /PRNewswire/ — Rosenberg & Parker is proud to announce the addition of Allison Thornhill as a Vice President and Renewable Energy Practice Leader. Based in the Atlanta area, Allison will be responsible for managing and further developing strategic growth opportunitie
Sir Alastair Cook joins GEDU as a Global Brand Ambassador
LONDON, Dec. 16, 2024 /PRNewswire/ — Global Education (GEDU) has been unveiled as the official Education Partner of the Professional Cricketers’ Association (PCA); with England cricketing legend Sir Alastair Cook as the Global Brand Ambassador. The PCA champions the ongoing interests of
UNITE DIGITAL, LLC CELEBRATES MULTIPLE AWARD WINS IN 2024
Unite Digital, LLC Wins Gold as Fastest Growing Company of the Year in Stevie Awards for Women in Business; Stacey Coopes, CEO, Takes Gold Winning Female Entrepreneur of the Year in 2024 TITAN Business Awards Competition; Stacey Coopes Ranked Fourth Out of Fifty Women in JP Morgan Chase Annual Wome
NEW YORK STOCK EXCHANGE PRE-MARKET UPDATE DECEMBER 16, 2024
Exclusive Market Insights Recorded Daily from the NYSE Trading Floor NEW YORK, Dec. 16, 2024 /PRNewswire/ — The New York Stock Exchange (NYSE) is proud to offer a new daily pre-market update and additional content directly from the iconic NYSE Trading Floor. Access the new Daily NYSE Pre-marke
